A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

Sexual dysfunction post-cancer treatment is underdiscussed, impacting patient and partner quality of life significantly. The EU-ProPER study reveals partners often lack information on treatment ...

Overall, men who have been treated for prostate cancer can expect quality of life equal to that as men in the general population, even those diagnosed with advanced disease, concludes the largest ...

Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment. Oral drugs to treat erectile dysfunction after radical treatment for ...

Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

The Government has issued an important statement on prostate cancer and the potential for a screening programme, starting ...